N H Dang - JoVE Visualize

Showing results (11-20 of 36) with videos related to

Pageof 4

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1992

CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activationY Torimoto, D M Rothstein, N H Dang, et al.

European Journal of Immunology|February 1, 1991

Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture systemA Yamada, Y Nojima, K Sugita, et al.

British Journal of Cancer|August 6, 2009

CD26 expression on T cell lines increases SDF-1-alpha-mediated invasionP A Havre, M Abe, Y Urasaki, et al.

Mutation Research|February 7, 2001

Overexpression of wild-type and nuclear-targeted catalase modulates resistance to oxidative stress but does not alter spontaneous mutant frequencies at APRTS E Schriner, A C Smith, N H Dang, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytesY Torimoto, N H Dang, E Vivier, et al.

Molecular Immunology|February 1, 1992

Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodiesY Torimoto, N H Dang, T Tanaka, et al.

Cellular Immunology|November 1, 1992

Activation of T cells through a T cell-specific epitope of CD45Y Torimoto, N H Dang, M Streuli, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991

1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activationN H Dang, Y Torimoto, K Shimamura, et al.

Clinical and Experimental Immunology|June 16, 2004

The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activationH Kobayashi, O Hosono, S Iwata, et al.

British Journal of Cancer|February 6, 2003

Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitorsU Aytac, K Sato, T Yamochi, et al.

Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:

Pageof 4

Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1992

CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activationY Torimoto, D M Rothstein, N H Dang, et al.

European Journal of Immunology|February 1, 1991

Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture systemA Yamada, Y Nojima, K Sugita, et al.

British Journal of Cancer|August 6, 2009

CD26 expression on T cell lines increases SDF-1-alpha-mediated invasionP A Havre, M Abe, Y Urasaki, et al.

Mutation Research|February 7, 2001

Overexpression of wild-type and nuclear-targeted catalase modulates resistance to oxidative stress but does not alter spontaneous mutant frequencies at APRTS E Schriner, A C Smith, N H Dang, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytesY Torimoto, N H Dang, E Vivier, et al.

Molecular Immunology|February 1, 1992

Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodiesY Torimoto, N H Dang, T Tanaka, et al.

Cellular Immunology|November 1, 1992

Activation of T cells through a T cell-specific epitope of CD45Y Torimoto, N H Dang, M Streuli, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1991

1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activationN H Dang, Y Torimoto, K Shimamura, et al.

Clinical and Experimental Immunology|June 16, 2004

The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activationH Kobayashi, O Hosono, S Iwata, et al.

British Journal of Cancer|February 6, 2003

Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitorsU Aytac, K Sato, T Yamochi, et al.

Pageof 4